Relationship Between Acute Severe Pancreatitis and Mitochondrial DNA
NCT04079777 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2019-09-06
Summary
Plasma mtDNA analysis aids in predicting pancreatic necrosis in severe acute pancreatitis patients.After the onset of severe acute pancreatitis, pancreatic necrosis and the content of mtDNA in plasma will increase, showing a significant positive correlation.
Conditions
- Severe Acute Pancreatitis
Interventions
- DRUG
-
Clinical treatment
Liquid Resuscitation, Anti-infection
Sponsors & Collaborators
-
First People's Hospital of Chenzhou
lead OTHER
Principal Investigators
-
Dixian DX · First People's Hospital of Chenzhou
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-07-01
- Primary Completion
- 2019-12-31
- Completion
- 2020-06-30
Countries
- China
Study Locations
More Related Trials
-
Markers in Acute Pancreatitis-1
NCT05279079 ·Status: COMPLETED
-
Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)
NCT05306028 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)
NCT05980221 ·Status: UNKNOWN ·Phase: NA
-
Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma
NCT04525209 ·Status: UNKNOWN
-
A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients
NCT05138302 ·Status: UNKNOWN
-
Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer
NCT03432624 ·Status: UNKNOWN
-
Early Detection of PDAC in Patients With Chronic Pancreatitis
NCT07104864 ·Status: COMPLETED
-
Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma
NCT06478056 ·Status: COMPLETED ·Phase: NA
-
ctDNA Assay in Patients With Resectable Pancreatic Cancer
NCT05052671 ·Status: RECRUITING
-
Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
NCT06041009 ·Status: RECRUITING
-
Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer
NCT05848154 ·Status: NOT_YET_RECRUITING
-
Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
NCT06849063 ·Status: RECRUITING
-
Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer
NCT04536220 ·Status: RECRUITING
-
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
NCT06378853 ·Status: COMPLETED
-
Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer
NCT00826982 ·Status: COMPLETED
-
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer
NCT04560270 ·Status: COMPLETED ·Phase: NA
-
The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma
NCT06807112 ·Status: NOT_YET_RECRUITING
-
ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma
NCT05479708 ·Status: ACTIVE_NOT_RECRUITING
-
Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer
NCT04977596 ·Status: COMPLETED
-
Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
NCT03048266 ·Status: RECRUITING
-
Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma
NCT05363007 ·Status: UNKNOWN ·Phase: PHASE2
-
Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma
NCT04565327 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
NCT07080697 ·Status: RECRUITING ·Phase: NA
-
Imaging Biomarkers of Pancreatic Function and Disease
NCT05659147 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis
NCT06241586 ·Status: COMPLETED